Enrolled 300% of the Expected Goal for a US-Based Phase 2 Urticaria Trial

Baton Rouge, LA –

Dr. Ira Thorla, one of our principal investigators who operates out of Louisiana Dermatology Associates, recently completed enrollment for a Phase 2 urticaria trial. Dr. Thorla was able to deliver some incredible results:

– Met enrollment goals rapidly, enrolling 300% of his expected goal

– Delivered site activation in just 41 days following the award, supporting rapid trial launch and early patient access

– Contributed over 20% of total study enrollment

Dr. Thorla is an experienced dermatologist who’s completed over 50 clinical trials with DelRicht Research, and this trial is just another example of how he’s committed to moving medicine forward!